Development and Validation of a Quantitative Determination Method for Meropenem in Blood Plasma for Therapeutic Drug Monitoring
Authors:
- 18 July 2020
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Chemistry Journal
- Vol. 54 (4) , 414-418
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Pharmacokinetics of the Meropenem Component of Meropenem‐Vaborbactam in the Treatment of KPC‐Producing Klebsiella pneumoniae Bloodstream Infection in a Pediatric PatientPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2018
- Therapeutic Drug Monitoring of Meropenem in Neonate with Necrotizing Enterocolitis: A ChallengeCase Reports in Infectious Diseases, 2016
- Short versus Long Infusion of Meropenem in Very-Low-Birth-Weight NeonatesAntimicrobial Agents and Chemotherapy, 2012
- Simultaneous Determination of 12 β-Lactam Antibiotics in Human Plasma by High-Performance Liquid Chromatography with UV Detection: Application to Therapeutic Drug MonitoringAntimicrobial Agents and Chemotherapy, 2011
- Simultaneous determination of eight β-lactam antibiotics in human serum by liquid chromatography–tandem mass spectrometryJournal of Chromatography B, 2011
- Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatinAntimicrobial Agents and Chemotherapy, 1996
- Pharmacokinetics of meropenem in patients with intra-abdominal infectionsAntimicrobial Agents and Chemotherapy, 1994